Search

Author/Creator Shu, ChengYi

1. Dissecting the tumor micro-environment in triple negative breast cancer identifies a mutually exclusive expression pattern of the immune co-inhibitory molecules B7-H4 and PD-L1. Issue 2 (December 2015)

Authors:
Shaffer, Donald; Cortez-Retamozo, Virna; Nagashima, Kumiko; Zi, Tong; Shu, ChengYi; Feldman, Igor; Neumeister, Veronique; Smith, Jeff; Zafari, Mohammad; Larson, Rebecca; Silver, Matthew; Mabry, Robert; Briskin, Michael; Novobrantseva, Tanya; Rimm, David; Sathyanarayanan, Sriram
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 3:Issue 2(2015)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Efficacy of anti-ICOS agonist monoclonal antibodies in preclinical tumor models provides a rationale for clinical development as cancer immunotherapeutics. Issue 2 (December 2015)

Authors:
Harvey, Christopher; Elpek, Kutlu; Duong, Ellen; Simpson, Tyler; Shu, ChengYi; Shallberg, Lindsey; Wallace, Matthew; Sathyanarayanan, Sriram; Mabry, Robert; Briskin, Michael; Michaelson, Jennifer; Gajewski, Thomas
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 3:Issue 2(2015)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search